Dr. West on FDA Approval of Frontline Alectinib in ALK+ NSCLC OncLive 0:55 7 years ago 124 Далее Скачать
Dr. West on FDA Approval of Frontline Osimertinib in EGFR+ NSCLC OncLive 3:14 6 years ago 216 Далее Скачать
Copy of Dr. West on FDA Approval of Frontline Osimertinib in EGFR+ NSCLC OncLive 0:40 6 years ago 38 Далее Скачать
Dr. Velcheti on Potential of Alectinib in Frontline ALK-Positive NSCLC OncLive 1:42 7 years ago 223 Далее Скачать
Dr. Neal Debates Whether Alectinib Will Become the Standard Frontline Thera for ALK+ NSCLC OncLive 1:27 7 years ago 201 Далее Скачать
Management of frontline ALK+ NSCLC: brigatinib vs. alectinib VJOncology 3:04 4 years ago 1 208 Далее Скачать
Dr. Gandhi Discusses the Role of Alectinib in ALK+ Lung Cancer OncLive 0:41 6 years ago 320 Далее Скачать
Dr. Wakelee on FDA Approval of Frontline Pembrolizumab in NSCLC OncLive 1:54 7 years ago 128 Далее Скачать
NAUTIKA1: safety and tolerability of neoadjuvant alectinib in ALK-positive NSCLC VJOncology 0:56 2 years ago 506 Далее Скачать
Dr. Christina Baik on Alectinib in Patients With ALK-Lung Cancer Targeted Oncology 1:12 8 years ago 484 Далее Скачать
